05/22/2026
✨ MultiFrax is helping push treatments beyond the traditional medspa model and into more flexible, mobile, and patient-centered environments. ✨
The FDA-approved, portable non-ablative fractional laser has brought forth one of the most significant advancements to laser engineering since its launch in 2025, as its the first laser capable of delivering two fractionated wavelengths ( the 1550nm and 1927nm) simultaneously.
Distributed exclusively by in the U.S, MultiFrax, now reports more than 100 device instalations in the U.S. alone.
💡 It matters because today’s aesthetic clients increasingly want treatments that are:
✨ low downtime
✨ preventative instead of corrective
✨ customizable
✨ accessible outside traditional clinical spaces
As aesthetics continues moving toward “maintenance culture” and subtle enhancement, device flexibility may become just as important as treatment efficacy itself. 📈✨
🔗 Full story:https://medesthetics.visitlink.me/YKmVBf